Table 1.
Clinical characteristics of patients underwent TBLC
| All (n = 17) | Fluoroscopy (n = 10) | ENB (n = 7) | P value | |
|---|---|---|---|---|
| Gender, M/F | 8/9 | 4/6 | 4/3 | 0.637 |
| Age, yrs. (Median, IQR) | 50.0(43.0–57.5) | 47.5(43.2–53.0) | 55.0(42.0–60.0) | 0.283 |
| Smoking History, Y/N | 7/10 | 4/6 | 3/4 | 1.000 |
| Environmental or occupational exposure, Y/N | 3/14 | 3/7 | 0/7 | 0.228 |
| Comorbidities, Y/N | 6/11 | 3/7 | 3/4 | 0.644 |
| FVC predicted, % (Median, IQR) | 86(66–104) | 80(62–105) | 87(67–103) | 0.625 |
| DLco predicted, % (Median, IQR) | 67(58–84) | 63(52–69) | 82(73–86) | 0.051 |
| 6MWD, m (Median, IQR) | 535(503–554) | 538(510–563) | 520(411–550) | 0.354 |
| Minimal SpO2 in 6MWT, % (Median, IQR) | 92(88–95) | 92(85–95) | 93(90–95) | 0.553 |
| Platelet count, × 109/L (Median, IQR) | 207(168–253) | 182(166–242) | 246(183–273) | 0.172 |
| PT, s (Median, IQR) | 13.1(12.8–13.5) | 13.2(12.9–13.5) | 12.8(12.6–13.2) | 0.221 |
| aPTT, s (Median, IQR) | 36.4(33.7–41.0) | 37.0(33.7–42.7) | 35.2(31.5–38.3) | 0.305 |
TBLC Transbronchial lung cryobiopsy, ENB Electromagnetic navigation bronchoscopy, IQR Interquartile range, FVC Forced vital capacity, DLco Carbon monoxide diffusing capacity, 6MWD Six-minute walk distance, SpO2 Oxygen saturation of pulse oximetry, 6MWT Six-minute walk test, PT Prothrombin time, APTT Partial thromboplastin time